S79. CAR strategies in solid tumours

by Rossig, C
Published 2014

The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting

by Kailayangiri, S, Altvater, B, Meltzer, J, Pscherer, S, Luecke, A, Dierkes, C, Titze, U, Leuchte, K, Landmeier, S, Hotfilder, M, Dirksen, U, Hardes, J, Gosheger, G, Juergens, H, Rossig, C
Published 2012

Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging

by Liebsch, L, Kailayangiri, S, Beck, L, Altvater, B, Koch, R, Dierkes, C, Hotfilder, M, Nagelmann, N, Faber, C, Kooijman, H, Ring, J, Vieth, V, Rossig, C
Published 2013

Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity

by Herzog, J., von Klot-Heydenfeldt, F., Jabar, S., Ranft, A., Rossig, C., Dirksen, U., Van den Brande, J., D'Incalci, M., von Luettichau, I., Grohar, P. J., Berdel, W. E., Burdach, St.
Published 2016

Research recommendations toward a better understanding of the causes of childhood leukemia

by Ziegelberger, G, Baum, C, Borkhardt, A, Cobaleda, C, Dasenbrock, C, Dehos, A, Grosche, B, Hauer, J, Hornhardt, S, Jung, T, Kammertoens, T, Lagroye, I, Lehrach, H, Lightfoot, T, Little, M P, Rossig, C, Sanchez-Garcia, I, Schrappe, M, Schuez, J, Shalapour, S, Slany, R, Stanulla, M, Weiss, W
Published 2011